MENU
LENZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LENZ Therapeutics (LENZ) Ownership - Who owns LENZ Therapeutics?

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

Profile

Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
536.31M
P/E Ratio
48.03
Total Cash
202.17M
Projected Growth
N/A
Total Debt
954K
Revenue
17.5M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.46
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price

Fundamentals

LENZ
Capitalization
536M
P/E Ratio
48.03
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
202M
Total Cash/Share
6.46
Total Debt
954K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.63%
Revenue
17.5M
ROE
N/A
Book Value
194M
P/B Ratio
2.77
Cash Flow
N/A
Earnings
-2.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
12.69
Current Revenue Per Employee
297619.06
Dividends Per Share - Security
N/A
EBITDA
-67.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.09
Shares Held By Institutions
1.71B
Shares Outstanding - Current
31.3M
Total Liabilities
16.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-40.630
View a ticker or compare two or three
LENZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com